Laserfiche WebLink
Federal Register/Vol. 80, No. 186/Friday, September 25, 2015/Proposed Rules 58053 <br /> Table 9: Active Pharmaceutical Ingredient in Residues in Single-Unit Dose Packaging <br /> Active h �rmaceutical ± Active: elro� <br /> P <br /> Di u;g HW <br /> ptYckaing type) 'Code <br /> inredietit in phraceuti <br /> Triple-Rinsed# Iiigpedient In','-,. <br /> Pack i>n 3 ar "l�>i a std <br /> Nicotine gum* P075 ND ND 0.00005 <br /> blisterpack) <br /> Nicotine patch* P075 ND 35.8 0.00005 <br /> (single use packet <br /> Warfarin** P001 ND 6.4 5.0 <br /> blisterpack) <br /> Physostigmine** P204 ND ND 100 <br /> (ampoule) <br /> *Method EPA 8720B <br /> **HPLC/UV <br /> ND =non-detect <br /> ii.Large Retailer.The second containers(Le.,100-count)of various detector).The data are summarized in <br /> stakeholder that submitted data to EPA dosage strengths of warfarin.The Table 10;the full results submitted to <br /> was a large retailer.Their data provide residues were quantified using HPLC— EPA are included in the docket for this <br /> the weight of active pharmaceutical UV/Vis(high performance liquid proposed rulemaking(EPA—HQ—RCRA— <br /> ingredient residues remaining in bulk chromatography/ultraviolet/visible light 2007-11932). <br /> Table 10: Warfarin Residues in 100-Count Dispensing Bottles <br /> Number of 'Total War aria Residue AV e <br /> Warfarin Bose Warton t n e�ttl <br /> j Bottles Tested in all Containers'(mg) <br /> Low 1 - 3 m 17 2.638 0.155 <br /> Medium 5 -7.5 m 18 12.820 0.712 <br /> High 10 m 18 21.530 1.196 <br /> The results from each of the first two the high dose of warfarin(10 mg)is Agency(CUPA)Forum Board to <br /> stakeholders reflect only the weight of 1.196 mg,if we assume that the residue conduct a study of residues remaining <br /> the active pharmaceutical ingredient, in the container has the same in pharmaceutical containers. <br /> not the full weight of the hazardous proportions of ingredients(i.e.,5%of Researchers at the University of <br /> waste residues. Since it is the Agency's the residue is warfarin and 95% of the California,Riverside(UCR)conducted <br /> position that it is the full weight of the residue are other ingredients),then the study and provided their results in <br /> hazardous waste residues and not just there would be an average of 23.92 maa report to Riverside County entitled, <br /> the weight of the active pharmaceutical of total hazardous waste residue Residue Analysis of P-Listed <br /> ingredients that must be counted in remaining in a 100-count bottle of 10 mg Pharmaceutical Containers for Warfarin <br /> determining generator status,we have pills of warfarin.The amount of and Nicotine.The results are <br /> used the results to calculate the weight hazardous waste residue remaining in a summarized below,but VCR's full <br /> of the total residues.In the retailer's 100-count bottle of pills is very small results are in the docket for this <br /> case,they have informed EPA that a compared with the residue that would proposed rulemaking(EPA—HCS-RCRA— <br /> typical pill with a 10 mg dose of remain in a 55-gallon drum,which is 2007-0932).13° <br /> Coumadin(brand name of warfarin) what the regulations for container The intent of the study was to <br /> weighs 200 mg.The active ingredient residues envisaged. investigate the third regulatory <br /> represents 10 mg,or 5% of the weight iii.Riverside County.The third approach suggested in the November <br /> of the pill,while 190 mg,or 95%of the stakeholder that provided data to EPA 2011 memo discussed previously.That <br /> weight of the pill,consists of was the Riverside County Department of <br /> ingredients other than the active Environmental Health,Hazardous ,ao See Exhibit 2 of the COPA Forum Board Trust <br /> ingredient.As indicated in Table 10,the Materials Management Branch.The Fund Grant Report submitted by the Riverside <br /> average weight of warfarin residue county received a grant from the County Department of Environmental Health nt the <br /> remaining in a frilly dispensed bottle of California Certified Unified Program conclusion of the grant. <br />